Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2026-01-02 @ 9:47 AM
Study NCT ID:
NCT03019003
Status:
COMPLETED
Last Update Posted:
2025-09-16
First Post:
2017-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-24
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-06
First Submit QC Date:
None
Study First Post Date:
2017-01-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-08-08
Results First Submit QC Date:
None
Results First Post Date:
2025-09-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED